Improved Performance of Point-of-Care Human Chorionic Gonadotropin Pregnancy Device

Clin Chem. 2018 Oct;64(10):1539-1541. doi: 10.1373/clinchem.2018.293076. Epub 2018 Aug 1.

Authors

Christopher W Farnsworth¹, Robert D Nerenz², Ann M Gronowski³

Affiliations

¹ Department of Pathology and Immunology, Washington University in St. Louis, St. Louis, MO.
² Department of Pathology and Laboratory Medicine, Dartmouth Geisel School of Medicine Hanover, NH.
³ Department of Pathology and Immunology, Washington University in St. Louis, St. Louis, MO gronowski@wustl.edu.

PMID: 30068691
DOI: 10.1373/clinchem.2018.293076

No abstract available

Publication types

Letter

MeSH terms

Chorionic Gonadotropin, beta Subunit, Human / urine*
False Negative Reactions
Female
Humans
Peptide Fragments / urine*
Point-of-Care Systems / standards*
Pregnancy
Pregnancy Tests* / instrumentation
Pregnancy Tests* / methods
Sensitivity and Specificity

Substances

Chorionic Gonadotropin, beta Subunit, Human
Peptide Fragments
urinary gonadotropin fragment